Skip to main content
. 2019 Dec 13;9:19127. doi: 10.1038/s41598-019-55552-6

Figure 1.

Figure 1

Treatment with S. obvelata reduced clinical signs of DSS-induced colitis in the C57BL/6 mice. (A) Survival rate in experimental period. (B) Weight change during trial, expressed as percentage change from day 0. C) Compare the DAI in all study groups. *Compared to the control group (P < 0/005). #Compared to the DSS colitis group (P < 0/005).